Form 4: Jack Schuler Reports Conversion of Preferred Stock and Grant of Stock Options in Biodesix Inc.

Director Jack Schuler reports the conversion of Series A Non-Voting Convertible Preferred Stock into common stock and the grant of restricted stock units and stock options in Biodesix Inc.

Summary

• Jack Schuler, a director and 10% owner of Biodesix Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 23, 2024, Schuler converted 2,174 shares of Series A Non-Voting Convertible Preferred Stock into 86,960 shares of common stock following stockholder approval on May 21, 2024.
• Schuler also received 46,686 restricted stock units (RSUs) and 37,050 stock options on May 21, 2024, which vest on March 31, 2025, subject to continued service.
• Following these transactions, Schuler beneficially owns 30,794,682 shares of common stock indirectly through the Jack W. Schuler Living Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The conversion of preferred stock simplifies the capital structure, and the equity grants align management interests with shareholders. There are no explicitly negative aspects.

Positives

• The conversion of preferred stock to common stock simplifies the capital structure of Biodesix Inc.
• The grant of RSUs and stock options aligns Schuler's interests with those of the company and its shareholders, incentivizing continued service and performance.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The conversion of preferred stock and grant of equity compensation are common practices.

Comparison to Industry Standards

• Equity compensation packages, including RSUs and stock options, are standard practice in the biotechnology industry to attract and retain talent.
• Vesting schedules of one year are common, aligning with industry norms for incentivizing long-term commitment.
• Conversion of preferred stock to common stock is a typical corporate action to simplify the capital structure, similar to actions taken by companies like Moderna and BioNTech after significant milestones.

Stakeholder Impact

• Shareholders may view the conversion of preferred stock as a positive simplification of the company's capital structure.
• Employees may be motivated by the equity grants to a key member of the board.

Key Dates